THNR

26.51 -0.37%
Amplify Weight Loss Drug & Treatment ETF NYSE Arca ETF Index and Sector ETFs
Open in Risen →

Amplify Weight Loss Drug & Treatment ETF (THNR) is an exchange-traded fund trading on NYSE Arca. This page shows THNR holdings, historical performance, and technical indicators including RSI, MACD, and the 52-week price range.

Technical Analysis

RSI (14) 55.0 Neutral
Volume 3.2K

ETF Profile

AUM $4.2M
Expense Ratio 0.25%
Holdings 21

Top Holdings

Name Weight Value
Novo Nordisk A/S 11.89% $493,589
ELI LILLY AND COMPANY 11.56% $480,119
REGENERON PHARMACEUTICALS, INC. 6.77% $281,240
AMGEN INC. 6.27% $260,369
CHUGAI PHARMACEUTICAL CO., LTD. 6.00% $248,982
CSPC PHARMACEUTICAL GROUP LIMITED 5.03% $208,923
Arrowhead Pharmaceuticals Inc 4.96% $206,094
ABBVIE INC. 4.75% $197,263
ASTRAZENECA PLC 4.66% $193,275
PFIZER INC. 4.62% $191,730

Take THNR further

Set alerts on THNR

Get notified when Amplify Weight Loss Drug & Treatment ETF hits your price targets or technical conditions are met.

Get Started Free